{"id":12865,"date":"2025-08-07T17:55:54","date_gmt":"2025-08-07T12:25:54","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=12865"},"modified":"2025-08-07T18:57:47","modified_gmt":"2025-08-07T13:27:47","slug":"medistep-healthcare-ipo-opens","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/medistep-healthcare-ipo-opens\/","title":{"rendered":"Medistep Healthcare IPO Opens: Key Details Investors Shouldn\u2019t Miss"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]Medistep Healthcare Limited is set to launch its Initial Public Offering (IPO), offering investors a chance to participate in a company that operates in the <\/span>pharmaceutical sector<\/span><\/a>. The company is involved in both manufacturing and trading a diverse range of products, including pharmaceuticals, intimate care, surgical, and nutraceutical items. This article provides key details about the <\/span>Medistep Healthcare IPO<\/span><\/a> for prospective investors, offering a deeper dive into the company’s profile, financial performance, and future plans.<\/span><\/p>\n

This article provides key details about the Medistep Healthcare IPO details for prospective investors.<\/span><\/p>\n

<\/span>About Medistep Healthcare Ltd.<\/b><\/span><\/h2>\n

Established in 2023, Medistep Healthcare Limited is a pharmaceutical company that manufactures and trades high-quality healthcare and wellness products.<\/span><\/p>\n

The company’s diverse product portfolio includes sanitary pads under the brand name DRYSTEP, and energy powders under the brand VITASTEP Z. They also trade a wide variety of third-party products, including pharmaceutical formulations like anti-inflammatory drugs, antibiotics, and surgical products such as cotton and bandages.<\/span><\/p>\n

The business model is driven by orders, which helps in optimizing resources and maintaining supply efficiency. The company’s focus on quality, with a diverse product portfolio that caters to a broad customer base, is one of its core strengths.<\/span><\/p>\n

<\/span>Medistep Healthcare IPO Details<\/b><\/span><\/h2>\n

The Medistep Healthcare IPO is a Fixed Price Issue and an SME IPO aiming to raise \u20b916.10 crore. It consists of a fresh issue of 37.44 lakh shares. The IPO will be listed on the NSE SME platform.<\/span><\/p>\n

\"\"<\/a><\/p>\n

<\/span>Important IPO Timeline<\/b><\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n
Event<\/b><\/td>\nDate<\/b><\/td>\n<\/tr>\n
IPO Open Date<\/b><\/td>\nFri, Aug 8, 2025<\/span><\/td>\n<\/tr>\n
IPO Close Date<\/b><\/td>\nTue, Aug 12, 2025<\/span><\/td>\n<\/tr>\n
Tentative Allotment<\/b><\/td>\nWed, Aug 13, 2025<\/span><\/td>\n<\/tr>\n
Initiation of Refunds<\/b><\/td>\nThu, Aug 14, 2025<\/span><\/td>\n<\/tr>\n
Credit of Shares to Demat<\/b><\/td>\nThu, Aug 14, 2025<\/span><\/td>\n<\/tr>\n
Tentative Listing Date<\/b><\/td>\nMon, Aug 18, 2025<\/span><\/td>\n<\/tr>\n
Cut-off time for UPI mandate confirmation<\/b><\/td>\n5 PM on Aug 12, 2025<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Key IPO Details<\/b><\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Event<\/b><\/td>\nDetails<\/b><\/td>\n<\/tr>\n
IPO Date<\/b><\/td>\nAugust 8, 2025 to August 12, 2025<\/span><\/td>\n<\/tr>\n
Listing Date<\/b><\/td>\n–<\/span><\/td>\n<\/tr>\n
Face Value<\/b><\/td>\n\u20b910 per share<\/span><\/td>\n<\/tr>\n
Issue Price<\/b><\/td>\n\u20b943 per share<\/span><\/td>\n<\/tr>\n
Lot Size<\/b><\/td>\n3,000 Shares<\/span><\/td>\n<\/tr>\n
Sale Type<\/b><\/td>\nFresh Capital<\/span><\/td>\n<\/tr>\n
Total Issue Size<\/b><\/td>\n37,44,000 shares (aggregating up to \u20b916.10 Cr)<\/span><\/td>\n<\/tr>\n
Reserved for Market Maker<\/b><\/td>\n1,89,000 shares (aggregating up to \u20b90.8127 Cr)<\/span><\/td>\n<\/tr>\n
Net Offered to Public<\/b><\/td>\n35,55,000 shares (aggregating up to \u20b915.29 Cr)<\/span><\/td>\n<\/tr>\n
Issue Type<\/b><\/td>\nFixed Price IPO<\/span><\/td>\n<\/tr>\n
Listing At<\/b><\/td>\nNSE SME<\/span><\/td>\n<\/tr>\n
Shareholding (Pre-Issue)<\/b><\/td>\n1,04,65,546 shares<\/span><\/td>\n<\/tr>\n
Shareholding (Post-Issue)<\/b><\/td>\n1,42,09,546 shares<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Lot Size of Medistep Healthcare<\/b><\/span><\/h2>\n\n\n\n\n\n\n
Application<\/b><\/td>\nLots<\/b><\/td>\nShares<\/b><\/td>\nAmount<\/b><\/td>\n<\/tr>\n
Individual investors (Retail) (Min)<\/b><\/td>\n2<\/span><\/td>\n6,000<\/span><\/td>\n\u20b92,58,000<\/span><\/td>\n<\/tr>\n
Individual investors (Retail) (Max)<\/b><\/td>\n2<\/span><\/td>\n6,000<\/span><\/td>\n\u20b92,58,000<\/span><\/td>\n<\/tr>\n
HNI (Min)<\/b><\/td>\n3<\/span><\/td>\n9,000<\/span><\/td>\n\u20b93,87,000<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/span>Medistep Healthcare Ltd. Financials<\/b><\/span><\/h2>\n

The company has demonstrated impressive financial growth. The total income for FY25 stood at \u20b949.66 crore, a significant increase from \u20b931.63 crore in FY24. Profit After Tax (PAT) also saw a substantial rise, from \u20b92.91 crore in FY24 to \u20b94.14 crore in FY25. This growth highlights the company’s strong operational performance and effective management.<\/span><\/p>\n

<\/span>Key Performance Indicators (as of March 31, 2025)<\/b><\/span><\/h3>\n